| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Marketing Direct > The Power Of Face-To-Face Marketing: Using Exhibitions As A Form Of Direct Marketing |
|
Digg It - The Power Of Face-To-Face Marketing: Using Exhibitions As A Form Of Direct Marketing
You start by thinking that when exhibiting at a show, to market direct to the public or to trade, you will more th According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product an likely be stood within metres of your competition. If you were not exhibiting though, then your competitors wil ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in be there anyway so this point should not in anyway affect your decision to exhibit. - In terms of actual exhibit lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ng, you know that you are dealing with a targeted market at exhibitions, with the people who do walk through the d here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe or; clearly people have chosen to attend such an event. This would suggest that they have some involvement or genu d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ne interest with regards to your field. - If you have a genuinely good product, exhibitions also give you a very ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc good sales environment on which to push for new business. What can be very important is getting your sales area pe easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi fect. Choosing the right exhibition stand design and the right spot will all affect how well you do. Exhibitions nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically re also fantastic for doing live demonstrations and for companies who for example, sell portable pop-up display st and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ nds, using an exhibitor’s exhibition, to demonstrate this pop-up banner is the perfect opportunity. The product be ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ng sold becomes more tangible for the potential customer and the sales job potentially becomes easier. This type ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a of direct marketing can also be considered by some people to be quite positive in that people who want to be sold dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod o, are the ones being targeted this way. No junk email, no cold calling. This type of direct selling can be consid cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin red a positive way of connecting with future customers and the relationship from the beginning tends to be one whi tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen h is built on more familiarity and understanding, with both parties having met face-to-face from the beginning. I t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel terms of sales leads and actual sales, percentages can be high, due to high number of quality visitors at these e ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust xhibitions. Someone attending the London Caravans Exhibition in Excel exhibition centre for example, are likely to y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products have a serious interest in caravans and similar products. You can potentially make more leads in a 2 or 3 exhibiti . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de n than you might in a few weeks worth of cold calling. Having an exhibition stand at an event will cost a certain elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip amount but the cost offset against the number of sales leads can mean that it is a worthwhile venture. Try it once tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Working From Home Opportunities For 2007 How to Get the Best Out of Trade Show Services
|